基于影像组学的腰椎退行性疾病手术疗效及术后并发症预测模型构建与验证:一项前瞻性队列研究

注册号:

Registration number:

ChiCTR2400082283 

最近更新日期:

Date of Last Refreshed on:

2024-05-16 19:28:57 

注册时间:

Date of Registration:

2024-03-26 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

基于影像组学的腰椎退行性疾病手术疗效及术后并发症预测模型构建与验证:一项前瞻性队列研究

Public title:

Construction and validation of the surgical outcomes and postoperative complications prediction model for lumbar degenerative disease based on radiomics: a prospective cohort study

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于影像组学的腰椎退行性疾病手术疗效及术后并发症预测模型构建与验证:一项前瞻性队列研究

Scientific title:

Construction and validation of the surgical outcomes and postoperative complications prediction model for lumbar degenerative disease based on radiomics: a prospective cohort study

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

吴超 

研究负责人:

桑大成 

Applicant:

Chao Wu 

Study leader:

Dacheng Sang 

申请注册联系人电话:

Applicant telephone:

+86 177 5483 6898

研究负责人电话:

Study leader's
telephone:

+86 134 2616 0593

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

wuchao9227@163.com

研究负责人电子邮件:

Study leader's E-mail:

dachengsang1616@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

安徽省芜湖市镜湖区赭山西路2号

研究负责人通讯地址:

安徽省芜湖市镜湖区赭山西路2号

Applicant address:

No. 2, Zheshan West Road, Jinghu District, Wuhu City, Anhui Province

Study leader's address:

No. 2, Zheshan West Road, Jinghu District, Wuhu City, Anhui Province

申请注册联系人邮政编码:

Applicant postcode:

241000

研究负责人邮政编码:

Study leader's postcode:

241000

申请人所在单位:

皖南医学院第一附属医院(皖南医学院弋矶山医院)

Applicant's institution:

The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)

研究负责人所在单位:

皖南医学院第一附属医院(皖南医学院弋矶山医院)

Affiliation of the Leader:

The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

(2024)伦审第(12)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

皖南医学院弋矶山医院科研与新技术伦理委员会

Name of the ethic committee:

Scientific Research and New Technology IRB of Wannan Medical College Yijishan Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2024-03-12 00:00:00

伦理委员会联系人:

吴佩

Contact Name of the ethic committee:

Pei Wu

伦理委员会联系地址:

中国安徽省镜湖区芜湖市赭山西路2

Contact Address of the ethic committee:

No. 2, Zheshan West Road, Jinghu District, Wuhu City, Anhui

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 553 573 9209

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

皖南医学院第一附属医院(皖南医学院弋矶山医院)

Primary sponsor:

The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)

研究实施负责(组长)单位地址:

安徽省芜湖市镜湖区赭山西路2号

Primary sponsor's address:

No. 2, Zheshan West Road, Jinghu District, Wuhu City, Anhui Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

安徽省

市(区县):

芜湖市

Country:

China

Province:

Anhui

City:

Wuhu

单位(医院):

皖南医学院第一附属医院(皖南医学院弋矶山医院)

具体地址:

安徽省芜湖市镜湖区赭山西路2号

Institution
hospital:

The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)

Address:

No. 2, Zheshan West Road, Jinghu District, Wuhu City, Anhui Province

经费或物资来源:

皖南医学院第一附属医院(弋矶山医院)引进人才专项科研基金项目

Source(s) of funding:

The Talent Introduction Special Research Fund Project of the First Affiliated Hospital of Wannan Medical College (Yijishan Hospital)

研究疾病:

腰椎退行性疾病  

Target disease:

Lumbar degenerative disease

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

I期临床试验 

Study phase:

1

研究设计:

队列研究 

Study design:

Cohort study 

研究目的:

1.构建腰椎退行性疾病图像数据单组识别模块,收集影像组学数据资料,高通量识别分析影像学特征性数据,用于构建临床预测模型。2.基于影像组学数据构建并验证腰椎退行性疾病术后复发或再手术预后相关预测模型,向同行推广应用本项目开发验证的预测模型,为降低术后复发/再手术发生率提供可干预靶点。  

Objectives of Study:

1. Construct a single-group identification module for lumbar degenerative disease image data, collect radiomics data, and use high-throughput identification and analysis of imaging characteristic data to build a clinical prediction model. 2. Construct and verify a prediction model related to the prognosis of postoperative recurrence or reoperation of lumbar degenerative disease based on radiomics data, promote the application of the prediction model developed and verified in this project to peers, and provide intervention options to reduce the incidence of postoperative recurrence/reoperation target.

药物成份或治疗方案详述:

包括建模和验证 

Description for medicine or protocol of treatment in detail:

Including two parts: modeling part and validation part 

纳入标准:

Inclusion criteria

排除标准:

1:有 X 线片、CT、MRI 扫描禁忌症患者;2:哺乳期和妊娠期妇女;3: 精神疾病患者等特殊人群;4: 依从性较差不能完成研究者;5: 研究人员认为不适合纳入研究的其它情况。

Exclusion criteria:

1: Patients with contraindications to X-rays, CT, and MRI scans; 2: Breastfeeding and pregnant women; 3: Special groups such as patients with mental illness; 4: Those with poor compliance and unable to complete the study; 5: Researchers believe that it is not possible for inclusion in the study due to other situations.

研究实施时间:

Study execute time:

From 2024-04-01 00:00:00 To 2029-03-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-04-01 00:00:00 To 2029-03-31 00:00:00

干预措施:

Interventions:

组别:

建模组/验证组

样本量:

500

Group:

Modeling group/ Validation Group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

安徽省 

市(区县):

芜湖市 

Country:

China

Province:

Anhui

City:

Wuhu

单位(医院):

皖南医学院第一附属医院(皖南医学院弋矶山医院) 

单位级别:

三甲 

Institution
hospital:

The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

内蒙古 

市(区县):

 

Country:

China

Province:

Inner Mongolia

City:

单位(医院):

赤峰学院附属医院 

单位级别:

三甲 

Institution
hospital:

Affiliated Hospital of Chifeng University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

影像学检查

指标类型:

主要指标

Outcome:

Imageological examination

Type:

Primary indicator

测量时间点:

术前、术后3天、1个月、3个月、6个月、1年、2年、3年、4年、5年

测量方法:

X线平片、CT、MRI图像

Measure time point of outcome:

3 days after surgery, 1 month, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years and 5 years

Measure method:

X-ray, CT, MRI images

指标中文名:

实验室检查

指标类型:

次要指标

Outcome:

Laboratory inspections

Type:

Secondary indicator

测量时间点:

术前、术后3天

测量方法:

Measure time point of outcome:

Before surgery, 3 days after surgery

Measure method:

指标中文名:

围手术期情况

指标类型:

次要指标

Outcome:

Condition during perioperative period

Type:

Secondary indicator

测量时间点:

围术期

测量方法:

Measure time point of outcome:

Peri operation period

Measure method:

指标中文名:

临床功能评估

指标类型:

主要指标

Outcome:

Clinical function evaluation

Type:

Primary indicator

测量时间点:

术前、术后3天、1个月、3个月、6个月、1年、2年、3年、4年、5年

测量方法:

VAS疼痛评分、ODI评分、JOA评分、SF-36评分、查尔森合并症指数(CCI)、瑞士脊柱狭窄问卷 (SSS)等

Measure time point of outcome:

Before surgery, 3 days after surgery, 1 month, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years and 5 years

Measure method:

VAS scale,ODI scale, JOA scale, SF-36 scale,Charlson Comorbidity Index (CCI),Swiss Spinal Stenosis Questionnaire (SSS) etc

指标中文名:

术后并发症

指标类型:

次要指标

Outcome:

Postoperative complications

Type:

Secondary indicator

测量时间点:

术后3天、1个月、3个月、6个月、1年、2年、3年、4年、5年

测量方法:

切口渗液、切口愈合不良、神经功能恶化、血肿、邻近节段退变、非融合术后复发性LDH、内固定相关并发症等

Measure time point of outcome:

3 days after surgery, 1 month, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years and 5 years

Measure method:

Incisional exudate, poor incisional healing, neurological deterioration, hematoma, adjacent segment degeneration, recurrent LDH after non-fusion surgery, internal fixation-related complications,etc

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 0 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

N/A

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例报告表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Report From, CRF

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2024-03-26 10:12:19